Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$41.06 -0.17 (-0.41%)
As of: Oct 21, 2026 · 3:04 PM EDT

Supernus Pharmaceuticals (SUPN) Notes Payables (2022 - 2023)

Updated

Supernus Pharmaceuticals (SUPN) reported Notes Payables of $402.5 million for Q1 2023, up 0.1% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Notes Payables (2022 - 2023) Analysis & Trends

At the end of FY2022, Supernus Pharmaceuticals posted Notes Payables of $401.97 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.82 Bn 1,105.41 Bn 19.71 Bn
2 Johnson & Johnson 617.41 Bn 535.94 Bn 17.26 Bn
3 AbbVie 501.29 Bn 474.40 Bn 12.70 Bn
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn
5 Novartis Ag 297.07 Bn 261.06 Bn 11.24 Bn
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn
7 Amgen 236.34 Bn 191.74 Bn 7.24 Bn
8 Gilead Sciences 191.00 Bn 165.20 Bn 6.22 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn
10 Supernus Pharmaceuticals 2.38 Bn 1.04 Bn 185.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 402.50 Mn
Dec 31, 2022 401.97 Mn
API Access

Supernus Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=SUPN&period=max&api_key=YOUR_API_KEY